William Blair Investment Management LLC trimmed its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 1.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,119,581 shares of the medical instruments supplier’s stock after selling 18,209 shares during the quarter. William Blair Investment Management LLC owned 1.87% of Merit Medical Systems worth $96,541,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also made changes to their positions in the company. Irenic Capital Management LP purchased a new position in Merit Medical Systems during the second quarter valued at approximately $37,623,000. The Manufacturers Life Insurance Company acquired a new position in Merit Medical Systems in the 2nd quarter valued at approximately $33,591,000. Bank of New York Mellon Corp purchased a new stake in Merit Medical Systems in the 2nd quarter worth approximately $28,470,000. J. Goldman & Co LP purchased a new stake in Merit Medical Systems in the 2nd quarter worth approximately $16,835,000. Finally, Maverick Capital Ltd. lifted its position in Merit Medical Systems by 46.9% in the 1st quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier’s stock worth $49,222,000 after buying an additional 227,915 shares in the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on MMSI shares. JPMorgan Chase & Co. lifted their target price on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research note on Friday, October 30th. Zacks Research downgraded shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 19th. Raymond James Financial reiterated an “outperform” rating and set a $100.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st. BTIG Research lifted their price objective on Merit Medical Systems from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Friday, October 30th. Finally, Barrington Research set a $114.00 price objective on Merit Medical Systems in a research report on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Merit Medical Systems has a consensus rating of “Moderate Buy” and an average target price of $105.55.
Check Out Our Latest Stock Analysis on Merit Medical Systems
Merit Medical Systems Stock Performance
NASDAQ:MMSI opened at $86.63 on Monday. The stock’s 50 day moving average price is $88.02 and its 200 day moving average price is $77.40. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.85. The company has a market capitalization of $5.19 billion, a P/E ratio of 32.57, a P/E/G ratio of 2.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.42, a quick ratio of 3.05 and a current ratio of 4.52.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.08. The firm had revenue of $416.24 million for the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.92 earnings per share. On average, research analysts forecast that Merit Medical Systems, Inc. will post 3.86 EPS for the current fiscal year.
Merit Medical Systems Profile
Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.
Featured Articles
- Five stocks we like better than Merit Medical Systems
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report).
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
